Transcranial Direct Current Stimulation for Chronic Pain

Overseen By Syreese Fuller

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Emory University

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

100 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will examine the effectiveness of tDCS (Transcranial Direct Current Stimulation) in reducing chronic pain when used with Emory Healthcare Veterans Program (EHVP)-ABHP (Accelerated Behavioral Health Program) participants as measured by the Pain, Enjoyment of Life and General Activity Scale (PEG).

Who Is on the Research Team?

Sheila Rauch, PhD

Principal Investigator

Emory University

Are You a Good Fit for This Trial?

Inclusion Criteria

I am between 18 and 89 years old.

I am willing to use tDCS on myself and complete all required assessments.

Have an established PCP (Primary Care Provider) or pain management provider

Exclusion Criteria

I am currently taking Felbamate.

I have had brain surgery in the past.

I am currently taking sodium channel blocker medications.

What Are the Treatments Tested in This Trial?

Interventions

• tDCS

How Is the Trial Designed?

Group I: Transcranial Direct Current Stimulation (tDCS) plus accelerated Behavioral Health Program Experimental Treatment 1 Intervention

Participants will receive short, daily tDCS treatment sessions for two weeks. Starting Day 1, tDCS will be administered with a constant current intensity of 2 mA for 20 min per session for up to 10 sessions over 2 weeks.

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials

1,735

Recruited

2,605,000+